Related Experiment Video
Updated: Jun 15, 2025
Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging
Published on: June 21, 2011
Application progress of nanomaterials in the treatment of prostate cancer
Xuewu Wu1, Longtu Ma1, Yang Zhang2
1The Second Hospital & Clinical Medical School, Lanzhou University, Gansu 730030, China.
Abstract:
Prostate cancer is one of the most common malignant tumors in men, which seriously threatens the survival and quality of life of patients. At present, there are serious limitations in the treatment of prostate cancer, such as drug tolerance, drug resistance and easy recurrence. Sonodynamic therapy and chemodynamic therapy are two emerging tumor treatment methods, which activate specific drugs or sonosensitizers through sound waves or chemicals to produce reactive oxygen species and kill tumor cells. Nanomaterials are a kind of nanoscale materials with many excellent physical properties such as high targeting, drug release regulation and therapeutic monitoring. Sonodynamic therapy and chemodynamic therapy combined with the application of nanomaterials can improve the therapeutic effect of prostate cancer, reduce side effects and enhance tumor immune response. This article reviews the application progress of nanomaterials in the treatment of prostate cancer, especially the mechanism, advantages and challenges of nanomaterials in sonodynamic therapy and chemodynamic therapy, which provides new ideas and prospects for research in this field.
Insights
Nanomaterials enhance prostate cancer treatment by combining sonodynamic and chemodynamic therapies. This approach improves efficacy, reduces side effects, and boosts anti-tumor immunity for better patient outcomes.
Area of Science:
- Oncology
- Nanomedicine
- Biomedical Engineering
Background:
- Prostate cancer poses significant survival and quality-of-life challenges due to treatment limitations like drug resistance and recurrence.
- Emerging therapies, sonodynamic therapy (SDT) and chemodynamic therapy (CDT), utilize sound waves or chemicals to generate reactive oxygen species for tumor cell death.
- Nanomaterials offer unique properties for targeted drug delivery, controlled release, and therapeutic monitoring in cancer treatment.
Purpose of the Study:
- To review the application progress of nanomaterials in prostate cancer treatment.
- To elucidate the mechanisms, advantages, and challenges of nanomaterials in SDT and CDT for prostate cancer.
- To provide new insights and future prospects for nanomaterial-based prostate cancer therapies.
Main Methods:
- Review of current literature on nanomaterial applications in sonodynamic therapy (SDT) for prostate cancer.
- Review of current literature on nanomaterial applications in chemodynamic therapy (CDT) for prostate cancer.
- Analysis of the synergistic effects and challenges of combining nanomaterials with SDT and CDT.
Main Results:
- Nanomaterial-enhanced SDT and CDT demonstrate improved therapeutic efficacy against prostate cancer.
- Combination therapies show potential for reduced side effects and enhanced anti-tumor immune responses.
- Nanomaterials facilitate targeted drug delivery, regulated release, and real-time monitoring in prostate cancer treatment.
Conclusions:
- Integrating nanomaterials with SDT and CDT represents a promising strategy for overcoming current prostate cancer treatment limitations.
- Further research into nanomaterial mechanisms and clinical translation is crucial for optimizing these advanced therapies.
- This review highlights the potential of nanomaterials to revolutionize prostate cancer treatment paradigms.
